Sort
326,823 grants matching “clinical trial”
Cancer Center Support Grant
$3,388,040Dan Theodorescu · University Of Colorado Denver · P30 · FY2016 · CA
Molecular and Clinical Manifestations of Matrix and Aggregate Myopathies
$3,387,942Carsten Bonnemann · National Institute Of Neurological Disorders And Stroke · ZIA · FY2014 · NS
TCD With Transfusions Changing to Hydroxyurea
$3,387,494Russell E Ware · St. Jude Children'S Research Hospital · R01 · FY2009 · HL
Statistical and Data Management Center (SDMC): Microbicide Trials Network
$3,387,468Elizabeth Renata Brown · Fred Hutchinson Cancer Research Center · UM1 · FY2014 · AI
STANFORD CENTER FOR CLINICAL AND TRANSLATIONAL EDUCATION AND RESEARCH (SCCTER)UL
$3,386,755Harry Bernard Greenberg · Stanford University · UL1 · FY2011 · RR
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS
$3,386,683Jay A Berzofsky · Division Of Clinical Sciences - Nci · ZIA · FY2016 · CA
The Indiana University-Ohio State University Maternal and Pediatric Precision in Therapeutics Data, Model, Knowledge, and Research Coordination Center (IU-OSU MPRINT DMKRCC)
$3,386,327Sara K Quinney · Indiana University Indianapolis · P30 · FY2023 · HD
Protein Trafficking In The Endosomal-Lysosomal System
$3,386,141Juan Bonifacino · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2024 · HD
Targeting Endosomal Receptors for Treatment of Chronic Pain
$3,385,528Nigel W Bunnett · New York University · R01 · FY2020 · DE
ctsa infrastructure for clinical trials
$3,385,130Robert A. Rizza · Mayo Clinic Rochester · UL1 · FY2010 · RR
TAS::75 0849::TAS CLINICAL TRIALS MONITORING SERVICE
$3,385,096Robert Royds · Theradex Systems, Inc. · N02 · FY2012 · CA
Hormone-Related Cancers
$3,383,977Gretchen Gierach · Division Of Cancer Epidemiology And Genetics · ZIA · FY2017 · CA
Growth Control in Multiple Myeloma
$3,383,355University Of Arkansas Med Scis Ltl Rock · P01 · FY2004 · CA
The Therapy of CML
$3,383,296Richard E. Champlin · University Of Tx Md Anderson Can Ctr · P01 · FY2013 · CA
TAS::75 0893::TAS CLINICAL COORDINATING CENTER FOR THE NIDA CENTER FOR THE CLINI
$3,382,900Robert Lindblad · The Emmes Company, Llc · N01 · FY2010 · DA
Pediatric Eye Disease Investigator Group
$3,382,703Roy W Beck · Jaeb Center For Health Research, Inc. · U10 · FY2007 · EY
Primary Infection Resource Consortium (PIRC)
$3,380,278Susan Little · University Of California, San Diego · R24 · FY2021 · AI
EMB-001: A novel combination therapy for the treatment of cocaine-use disorder
$3,380,100Bruce McCarthy · Embera Neurotherapeutics, Inc. · U01 · FY2019 · DA
Addressing emotional distress in dyads of persons with a Young Onset Dementia (YOD) and their care-partners
$3,379,666Ana-Maria Vranceanu · Massachusetts General Hospital · RF1 · FY2025 · AG
TAS::75 0893::TAS CLINICAL COORDINATING CENTER FOR THE NIDA CENTER FOR THE CLINI
$3,378,969Robert Lindblad · The Emmes Company, Llc · N01 · FY2014 · DA
Mechanisms of naturally-acquired immunity to malaria
$3,378,961Peter Crompton · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
IGF::OT::IGF: DATA, STATISTICS, AND CLINICAL TRIAL SUPPORT FOR NIDA (DSC4). N01DA-14-2237. PERIOD OF PERFORMANCE: JUNE 19, 2014 TO JUNE 18, 2019.
$3,378,726Paul Vanveldhuisen · The Emmes Company, Llc · N01 · FY2014 · DA
Investigations of Methylmalonic Acidemia and Related Disorders
$3,378,385Charles P Venditti · National Human Genome Research Institute · ZIA · FY2025 · HG
Utah Trial Innovation Center
$3,378,320Jonathan Michael Dean · University Of Utah · U24 · FY2021 · TR
A Placebo-Controlled Effectiveness in INPH Shunting (PENS) Trial
$3,378,298Mark Gregory Luciano · Johns Hopkins University · U01 · FY2022 · NS